Real-world lipid lowering effects of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: A single-centre study
Keyword(s):
2019 ◽
Vol 25
(1)
◽
pp. 49-53
Keyword(s):
2017 ◽
Keyword(s):
2018 ◽
Vol 71
(11)
◽
pp. A1112
◽
Keyword(s):
2017 ◽
Vol 69
(11)
◽
pp. 1014
Keyword(s):